生命科学资讯

AstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC

Politicization runs deeper than ever at FDA, risking long-term impacts

The biopharma industry outlook on 2026: Optimism and tension

Sanofi expects vaccine sales growth to dip amid ‘challenging environment’

AstraZeneca strengthens China ties with planned $15B investment

Tenpoint wins FDA nod for combination presbyopia eye drop

Lilly bets on Seamless, delving further into genetic medicine for hearing loss

Drugs for cancer, arthritis and HIV on Medicare’s list for 2028 price cuts

Halozyme buys a biotech startup; Cytokinetics launches heart drug

Regenxbio gene therapy trials suspended by FDA over safety worries

FDA lifts hold on an Intellia CRISPR drug trial

Roche, trailing in obesity, showcases new data for GLP-1 shot

An immune drug developer raises $50M to finance its eczema drug testing

China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says

Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time

Biotech investor Cormorant secures $150M for another SPAC deal

Express Scripts considering settlement in FTC insulin price lawsuit

The formula for biotech success in 2026: Confidence, resilience and funding

From detection to prevention: How sponsored testing can transform patient outcomes